MolNFT v1 · #50171 · protein
Human fdps synthase in complex with novel inhibitor
2RAH · Farnesyl pyrophosphate synthetase: “Human fdps synthase in complex with novel inhibitor”. X-ray diffraction, 3 ligands (11P, MG, SO4), 1 pocket (best druggability 0.79). MolNFT v1 #50171 on GenesisL1: 3D structure, binding sites and…
- PDB
- 2RAH
- Type
- protein
- Length
- 340 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Farnesyl pyrophosphate synthetase
- EC
- 2.5.1.1, 2.5.1.10
- UniProt
- P14324
- Ligands
- 11P, MG, SO4
- Pockets
- 1 · best druggability 0.79
Structure
x-ray diffraction · 1 distinct chain · 76% helix, 1% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Farnesyl pyrophosphate synthetase (EC 2.5.1.1, 2.5.1.10) | protein | 340 | 76% helix, 1% strand | P14324 |
Ligands and binding sites
- 11P · [(7R)-6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) · ligand · chains A
- MG · Magnesium ion · metal · chains A
- SO4 · Sulfate ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 542 | 0.79 | 0.86 | 57 | 11P, MG, SO4 |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P14324
- Elsewhere: RCSB PDB 2RAH · PDBe 2RAH · UniProt P14324
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.